Clinical trial
Novel Treatment for Diastolic Heart Failure in Women
NCT00206232 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00206232 |
|---|---|
| Title | Novel Treatment for Diastolic Heart Failure in Women |
| Official title | Novel Treatment for Diastolic Heart Failure in Women |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | Spironolactone |
| Enrollment | 48 |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: